On this episode of Stock Movers:
- Pfizer (PFE) shares fall after Pfizer forecasted little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit drugs with a series of pricey acquisitions.
- Paypal (PYPL) shares gain after the company applied to become a bank in the US by submitting applications to the Federal Deposit Insurance Corp. and the Utah Department of Financial Institutions.
- Stubhub (STUB) shares fall after the company received a downgrade at Citizens, which predicts that the ticketing platform will face more robust competition in 2026 and flagged headwinds from regulation

On this episode of Stock Movers: - Pfizer (PFE) shares fall after Pfizer forecasted little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit drugs with a series of pricey acquisitions. - Paypal (PYPL) shares gain after the company applied to become a bank in the US by submitting applications to the Federal Deposit Insurance Corp. and the Utah Department of Financial Institutions. - Stubhub (STUB) shares fall after the company received a downgrade at Citizens, which predicts that the ticketing platform will face more robust competition in 2026 and flagged headwinds from regulation

Listen for Short conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for Short conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Listen for short conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for short conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Pfizer Falls, Paypal Gains, Stubhub Falls After Ratings Downgrade

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/1e1c6df1-51ba-4342-8431-b3b50110707f/transcript

Bloomberg’s Nathan Hager focuses on three stocks for the week ahead. They include: Netflix, Tesla, and Meta.

Nathan previews what to expect from these companies in the week ahead with Ann Gehan, Bloomberg Earnings Reporter..

Bloomberg&rsquo;s Nathan Hager focuses on three stocks for the week ahead. They include: Netflix, Tesla, and Meta. Nathan previews what to expect from these companies in the week ahead with Ann Gehan, Bloomberg Earnings Reporter..

Week Ahead: Netflix, Tesla, and Meta

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/fe4ff9d9-b4a0-46de-8035-b4e5013a068e/transcript

Today's biggest winners and losers in the stock market, a look at the notable movers: 

On this episode of Stock Movers:

- CoreWeave (CRWV) shares plunged 20% in the first three sessions of the week as its debt tumbled to levels that typically indicate distress. The cost of protecting CoreWeave bonds against default rose to the highest intraday level on record, while swaps priced in a more than 60% chance of a default within the next five years. Despite the concerns, some investors and analysts, including Jensen Huang and Deutsche Bank, expressed confidence in the company, citing its strong customer base and demand for AI computing services.

- Eli Lilly's (LLY) Foundayo won the backing of the European Medicines Agency’s Committee for Medicinal Products for Human Use for obesity and type 2 diabetes. The recommendation for approval of the once-daily pill now goes to the European Commission for a final decision, which typically follows within about two months. Lilly is “working hard” to get ready to launch the pill in all 30 countries where an approval would be valid, according to Ken Custer, president of the drugmaker’s cardiometabolic unit.

- Tesla (TSLA) held a product reveal for its long-delayed Roadster sports car, showcasing a prototype with air thrusters that performed aerial stunts. The vehicle, designed in collaboration with SpaceX, features two seats and a Cybertruck-style steer-by-wire system, and is expected to start production in 2028. The Roadster is seen as a way to bring back excitement to the Tesla brand, which has experienced consecutive annual sales declines and criticism over a stagnant product lineup.

Today's biggest winners and losers in the stock market, a look at the notable movers:&nbsp;
On this episode of Stock Movers:
- CoreWeave (CRWV) shares plunged 20% in the first three sessions of the week as its debt tumbled to levels that typically indicate distress. The cost of protecting CoreWeave bonds against default rose to the highest intraday level on record, while swaps priced in a more than 60% chance of a default within the next five years. Despite the concerns, some investors and analysts, including Jensen Huang and Deutsche Bank, expressed confidence in the company, citing its strong customer base and demand for AI computing services.
- Eli Lilly's (LLY) Foundayo won the backing of the European Medicines Agency&rsquo;s Committee for Medicinal Products for Human Use for obesity and type 2 diabetes. The recommendation for approval of the once-daily pill now goes to the European Commission for a final decision, which typically follows within about two months. Lilly is &ldquo;working hard&rdquo; to get ready to launch the pill in all 30 countries where an approval would be valid, according to Ken Custer, president of the drugmaker&rsquo;s cardiometabolic unit.
- Tesla (TSLA) held a product reveal for its long-delayed Roadster sports car, showcasing a prototype with air thrusters that performed aerial stunts. The vehicle, designed in collaboration with SpaceX, features two seats and a Cybertruck-style steer-by-wire system, and is expected to start production in 2028. The Roadster is seen as a way to bring back excitement to the Tesla brand, which has experienced consecutive annual sales declines and criticism over a stagnant product lineup.

Weekly Roundup: CoreWeave Plunges, Eli Lilly Gained, Tesla Launches Roadster

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/d23180b9-ab94-4a4d-940a-b4e5015c6666/transcript

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Tim Stenovec, Carol Massar

- Alcoa (AA) shares rose as much as 6.3% after the aluminum producer reported third-quarter adjusted earnings that beat estimates, helped by higher aluminum production and prices.

- CoreWeave (CRWV) shares plunged 20% in the first three sessions of the week as its debt tumbled to levels that typically indicate distress. The cost of protecting CoreWeave bonds against default rose to the highest intraday level on record, while swaps priced in a more than 60% chance of a default within the next five years. Despite the concerns, some investors and analysts, including Jensen Huang and Deutsche Bank, expressed confidence in the company, citing its strong customer base and demand for AI computing services.

- MSCI adopted new rules that could push Strategy (MSTR) out of its global equity benchmarks, potentially triggering stock sales and adding pressure to the financing model behind Michael Saylor's Bitcoin holdings. The decision establishes financial tests that could render Strategy ineligible for inclusion in MSCI's global equity indexes, and an eventual removal could deal a blow to the crypto-treasury model pioneered by Strategy. A removal from the index could pressure Strategy's stock by shrinking the pool of investors required to hold it, with estimated potential sales of $2.8 billion due to MSCI exclusion and potentially another $8.8 billion if other indexes follow suit.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Tim Stenovec, Carol Massar - Alcoa (AA) shares rose as much as 6.3% after the aluminum producer reported third-quarter adjusted earnings that beat estimates, helped by higher aluminum production and prices. - CoreWeave (CRWV) shares plunged 20% in the first three sessions of the week as its debt tumbled to levels that typically indicate distress. The cost of protecting CoreWeave bonds against default rose to the highest intraday level on record, while swaps priced in a more than 60% chance of a default within the next five years. Despite the concerns, some investors and analysts, including Jensen Huang and Deutsche Bank, expressed confidence in the company, citing its strong customer base and demand for AI computing services. - MSCI adopted new rules that could push Strategy (MSTR) out of its global equity benchmarks, potentially triggering stock sales and adding pressure to the financing model behind Michael Saylor's Bitcoin holdings. The decision establishes financial tests that could render Strategy ineligible for inclusion in MSCI's global equity indexes, and an eventual removal could deal a blow to the crypto-treasury model pioneered by Strategy. A removal from the index could pressure Strategy's stock by shrinking the pool of investors required to hold it, with estimated potential sales of $2.8 billion due to MSCI exclusion and potentially another $8.8 billion if other indexes follow suit.

Closing Bell: Alcoa Rises, CoreWeave Plunges, Strategy Drops on MSCI Rules

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/3fde2561-24c5-40ec-b159-b4e501502483/transcript

Pfizer Falls, Paypal Gains, Stubhub Falls After Ratings Downgrade

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips